Connect with us

Business Wire

ARUP Laboratories Deploys World’s First AI-Augmented Ova and Parasite Assay

Business Wire

Published

on

Reading Time: 2 minutes

SALT LAKE CITY–(BUSINESS WIRE)–#AI–ARUP Laboratories (ARUP), a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI) based image analysis solutions for the diagnostics industry, have developed the world’s first AI-augmented ova and parasite detection tool.

“The collaboration with Techcyte has produced an AI-augmented detection tool that significantly advances our diagnostic capabilities in our parasitology lab,” said Adam Barker, PhD, director of Research and Development at ARUP. “This will allow for faster turnaround times, decreased costs, employee satisfaction and improved patient care.”

For laboratorians, digitally enabling the workflow will decrease the physical demands of looking through a microscope for extended periods of time, including eye fatigue and neuromuscular tension. The technology can quickly screen out negative results, allowing laboratorians to spend more time analyzing positive slides.

Techcyte’s digital diagnostics platform applies the latest in convolutional neural networks to pre-classify the fecal sample images captured by a 3DHISTECH Pannoramic 250-Flash III scanner. Pre-classifying the images using the Techcyte tool allows ARUP’s technologists to efficiently read stained glass slides manually and improves the accuracy of parasite detection.

“Microscopy-based diagnostic parasitology has remained woefully static for decades. We have successfully developed a pioneering breakthrough with this tool, the likes of which had previously been unimaginable by classically trained microbiologists,” said Dr. Marc Couturier, medical director of ARUP’s Parasitology labs.

The ova and parasite tool is the first of many projects that ARUP and Techcyte are co-developing. ARUP’s vast medical expertise and access to samples combined with Techcyte’s technical ability and digital evaluation platform will produce high quality algorithms that can be developed and applied to future unmet laboratory needs.

“This revolutionary partnership will combine ARUP’s vast expertise and reputation in the market with Techcyte’s AI-based image analysis capabilities to change the way lab diagnostics are performed,” said Ralph Yarro, CEO of Techcyte.

Medical labs, hardware manufacturers, hospitals, and clinics all benefit from Techcyte’s solutions. In 2019, Techcyte will deliver solutions for blood analysis, cervical cytology, and bacteriology.

About Techcyte

Headquartered in Lindon, Utah, Techcyte, Inc. was founded in 2013 as a technology transfer from the University of Utah with a mission to lower healthcare costs through artificial intelligence. Techcyte uses the power of deep machine learning to perform image analysis of whole slide images. Image analysis is required for widespread adoption of digital diagnostics in research, pharma, human, air quality, and veterinary diagnostic testing. Visit www.techcyte.com for more information.

About ARUP

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests. Rather than competing with its clients for physician office business, ARUP supports its clients’ existing test menus by offering highly complex and unique lab tests, with accompanying consultative support, to enhance their abilities to provide laboratory services. Visit www.aruplab.com for more information.

Contacts

Techcyte Media Contact:

Ben Cahoon, 801-980-0414

ben.cahoon@techcyte.com


ARUP Media Contacts:

Cyndee Holden, 801-583-2787, x- 3318

cynthia.holden@aruplab.com

Peta Owens-Liston, 801-583-2787, x- 3635

peta.liston@aruplab.com

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.

Business Wire

KARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. – KPTI

Business Wire

Published

on

Reading Time: 2 minutes

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 23, 2019 to file lead plaintiff applications in a securities class action lawsuit against Karyopharm Therapeutics Inc. (NasdaqGS: KPTI). Investor losses must relate to purchases of the Company’s shares between March 2, 2017 and February 22, 2019 or issued in connection with its April 2017 or May 2018 public offering. This action is pending in the United States District Court for the District of Massachusetts.

What You May Do

If you purchased shares of Karyopharm and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-kpti/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by September 23, 2019.

About the Lawsuit

On February 22, 2019, the Federal Drug Administration (“FDA”) reported serious concerns with the Company’s drug, selinexor. Specifically, the FDA concluded that, contrary to the Company’s prior assurances, “[t]reatment with selinexor is associated with significant toxicity” with “limited efficacy.” On this news, the price of Karyopharm’s shares plummeted.

The case is Allegheny County Employees’ Retirement System v. Karyopharm Therapeutics Inc., 1:19-cv-11597.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com
1-877-515-1850

Continue Reading

Business Wire

EAGLE BANCORP 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Eagle Bancorp, Inc. – EGBN

Business Wire

Published

on

Reading Time: 2 minutes

NEW ORLEANS–(BUSINESS WIRE)–Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 23, 2019 to file lead plaintiff applications in a securities class action lawsuit against Eagle Bancorp, Inc. (NasdaqCM: EGBN). Investor losses must relate to purchases of the Company’s securities between March 2, 2015 and July 17, 2019. This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased securities of Eagle Bancorp and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqcm-egbn/ to learn more. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by September 23, 2019.

About the Lawsuit

On July 17, 2019, the Company disclosed an increasing level of legal expenses resulting from ongoing internal and government investigations of “the Company’s identification, classification and disclosure of related party transactions; the retirement of certain former officers and directors; and the relationship of the Company and certain of its former officers and directors with a local public official.” On this news, the price of Eagle Bancorp’s shares plummeted.

The case is Stein v. Eagle Bancorp, Inc., 19-cv-06873.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com
1-877-515-1850

Continue Reading

Business Wire

DISNEY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Walt Disney Company – DIS

Business Wire

Published

on

Reading Time: 1 minute

NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Walt Disney Company (NYSE: DIS).

In August 2019, news media sources reported that a former Walt Disney Co. senior financial analyst had filed a series of whistleblower tips with the Securities and Exchange Commission against the Company alleging that its employees had utilized a variety of schemes to systematically overstate revenue by billions of dollars, including 2008-09 revenue possibly being overstated by up to $6 billion. The former employee also charged that Company executives were unresponsive to her attempts to report the issues and that she was ultimately fired soon after she contacted the SEC regarding the matter in August 2017.

KSF’s investigation is focusing on whether Disney’s officers and/or directors breached their fiduciary duties to Disney’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of Disney shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-dis/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner

lewis.kahn@ksfcounsel.com
1-877-515-1850

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Business Wire9 hours ago

KARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. – KPTI

Business Wire9 hours ago

EAGLE BANCORP 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Eagle Bancorp, Inc. – EGBN

Business Wire9 hours ago

DISNEY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Walt Disney Company – DIS

Business Wire9 hours ago

NATIONAL GENERAL 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against National General Holdings Corp. – NGHC

Business Wire9 hours ago

L BRANDS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against L Brands, Inc. – LB

Business Wire11 hours ago

Harvest Announces Resignation of Board Member and President

Business Wire12 hours ago

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Carbonite, Inc. and Encourages Investors to Contact the Firm Before September 30

Business Wire12 hours ago

Think Global Forum Unveils a Brand-New Identity

Business Wire13 hours ago

Shareholder Alert: Robbins Arroyo LLP Is Investigating the Officers and Directors of Sonim Technologies, Inc. (SONM) on Behalf of Shareholders

Business Wire13 hours ago

HIGHLANDS BANKSHARES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Highlands Bankshares, Inc. – HLND

Follow our Tweets

Trending

Please turn AdBlock off